Sigal Fatal
CIK: 0001850994
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CMMB
Chemomab Therapeutics Ltd.
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Fatal Sigal
Fatal Sigal (SEC CIK 0001850994) files insider reports with the SEC as Chief Financial Officer of Chemomab Therapeutics Ltd. (CMMB).
Signal8 holds 1 ownership filing by Fatal Sigal, a Form 3, filed on Apr 10, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Fatal Sigal's filings is in TEL AVIV.
Other insiders filing for Chemomab Therapeutics Ltd. (CMMB)
- Cohen Neil Harris, Director
- Melincoff Gwen A, Director
- Mor George Adi, Chief Executive Officer
- Darvish Nissim, Director
- Moses Alan Charles, Director
- Lawler John, Chief Development Officer